About NucleoTech
NucleoTech is building the infrastructure that unlocks brain therapeutics.
NucleoTech combines scientific expertise in neurobiology and BBB science with proven experience scaling ventures to exit. Our proprietary direct in vivo platform enables 100x throughput over conventional brain shuttle discovery, and our R&D team has already identified promising proprietary carriers advancing toward clinical development. We are a Delaware C-Corp with operations and R&D in Israel.
Management Team
Uriah Bekenstein, PhD
Co-Founder & CEO
Uriah Bekenstein, PhD
Neurobiologist with academic and biotechnology traction. Strong background in intellectual property and project strategy with scientific expertise in neurodegeneration, RNA biology and brain vasculature biology. Former IP Officer at Futuragene, with published work in leading scientific journals.
Naftali Cohen
Co-Founder & CBO
Naftali Cohen
Technology venture executive with twenty years of experience scaling companies to exit. Former CRO at MayStreet (acquired by LSEG) and partner and founding team member of LiquidityBook (acquired by FactSet).
Adi Koplovitz
Co-Founder & COO
Adi Koplovitz
Senior economist and strategist with expertise in large-scale operational and regulatory management. Led multi-billion NIS infrastructure reforms at Israel's Ministry of Communications, recognized in the Top 40 Under 40 for national impact.
Shachar Dagan, PhD
Head of Research
Shachar Dagan, PhD
Expert BBB researcher and former member of Harvard Medical School's Gu Lab - one of the world's leading groups in brain vascular biology and BBB drug delivery. Leads NucleoTech's research operations in Israel.
Industry Advisory Board
Christian Policard, PhD
Seasoned Biotech Executive (Sanofi C-Suite) & Venture Capitalist
Christian Policard, PhD
Seasoned Biotech Executive (Sanofi C-Suite) & Venture Capitalist
David C. Baker, MBA
MBA — Public Biotech CEO and executive (Shire, Merck)
David C. Baker, MBA
Public Biotech CEO and executive (Shire, Merck)
Julia Reznick, MBA
Biotech strategy & Finance. Executive (Pfizer, Teva)
Julia Reznick, MBA
Biotech strategy & Finance. Executive (Pfizer, Teva)
Pierre Morgon, PhD, LL.M, MBA
Pharma Veteran & Multi-Stage Biotech CEO
Pierre Morgon, PhD, LL.M, MBA
Pharma Veteran & Multi-Stage Biotech CEO
Immanuel Lerner, PhD
Biotech founder and CEO
Immanuel Lerner, PhD
Biotech founder and CEO
Scientific Advisory Board
Prof. Alon Friedman, MD, PhD
Renowned Pioneer in human BBB research
Prof. Alon Friedman, MD, PhD
Renowned Pioneer in human BBB research
Prof. Hermona Soreq, PhD
Renowned molecular neuroscientist, H-index 100
Prof. Hermona Soreq, PhD
Renowned molecular neuroscientist, H-index 100
Prof. Ayal Ben-Zvi, PhD
BBB and STORM microscopy expert
Prof. Ayal Ben-Zvi, PhD
BBB and STORM microscopy expert
Prof. Niv Papo, PhD
High-Affinity Protein Engineering expert
Prof. Niv Papo, PhD
High-Affinity Protein Engineering expert
Prof. Pablo Blinder, PhD
Multi-Modal BBB expert researcher
Prof. Pablo Blinder, PhD
Multi-Modal BBB expert researcher